This page contains a Flash digital edition of a book.
| PRIME PRoMotIon


Infiltration techniques In this study, 1 ml of Viscoderm® 20 mg/ml non-cross-linked HA was used in each session. Lidocaine 2% was administered approximately 1 cm from the labial commissures bilaterally, with 0.1 ml of product using a 30-gauge needle. Using the same puncture point, a 25-gauge needle


Figure 1 Injection using 27 G blunt cannula between the vermillion border and the white lip


and/or prolonged oedema have ever been reported — including in this study, our previous experiences, and in other studies using this material. Viscoderm® (IBSA Farmaceutici Italia) is a premium


quality HA manufactured according to GMP standards for active substances (EU GMP Part II) and recommendations from the World Health Organization. Manufactured synthetically through a process of Streptococcus equi fermentation, it has a molecular weight of over 1 million Daltons (1.4–2.1 x 106 Da) developed for use as an intradermal filler, and comes in three different concentrations (0.8%, 1.6% and 2%) as sterile 1 ml pre-filled syringes. Both during the study described and in those


previously undertaken, the side-effects observed included transient oedema, transient erythema, and ecchymosis associated with the infiltration technique and the material’s hygroscopic properties.


Materials and methods Twenty patients were recruited for the study (one man and 19 women) with a mean age of 55 years, who were in good health and had not undergone any aesthetic treatments during the previous 3 months. Photographic images were obtained using a polarised light source, followed by computerised processing of the wrinkles in the skin (Canfield Visia®), and using a normal digital camera, before treatment, 1 month after the second session, and 1 month after the third session. Infiltrations were performed on the vermillion border and lip contour twice every week for a total of three sessions.


was used to create the point of access in which the blunt cannula was introduced and, very slowly, a tunnel was created along the virtual channel between the vermillion border and the white lip (Figure 1). A total of 0.6 ml of product was infiltrated, initially using the anterograde technique, delivering a minimal portion in order to detach the tissue and minimise trauma, and afterwards using the retrograde technique. The remaining 0.4 ml of material was distributed inside the upper and lower vermilion borders by infiltrating the submucosal tissue and distributing it using the fanning technique, withdrawing the blunt cannula for all but the last 5 mm and then reintroducing it further down to perform two-to-three linear infiltrations for each half of the lip. The infiltration was always performed very slowly to respect the tissue and for the comfort of the patient.


Table 1. Average satisfaction scores with treatment Increased


Moisture Day 0


Day 30 Day 60


definition 2.94 2.64 2.42


3.64 3.35 2.66


Firmness Volume 3.14


2.50 2.42


2


1.93 1.83


4=unsatisfactory, 3=moderate, 2=good, 1=excellent


Table 2. Adverse events Side-effect


Pain during infiltration Pain after infiltration Erythema Oedema Pruritus


Discolouration Ecchymosis Other


Number of patients 8 0 1


7* 0 0 2


0 *Maximum of 48 hours prime-journal.com | October 2011 ❚


53


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84